NuPathe (NASDAQ: PATH) (Acquired)
Innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders such as migraine, Parkin....
Learn More
Get a Demo and See the Full Profile
Get a demo today to see profiles of NuPathe (NASDAQ: PATH) (Acquired) plus 5892 other startups.
Learn More
